Professor Paul Evans joins NC3Rs Board
The NC3Rs is a UK-based scientific organisation dedicated to replacing, refining and reducing the use of animals in research and testing (the 3Rs).
They collaborate with scientists and organisations from across the life sciences sector, nationally and internationally, including universities, the pharmaceutical, chemical and consumer products industries, other research funders, and regulatory authorities.
The work of the NC3Rs is overseen by its Board, which is currently chaired by Professor Stephen Holgate CBE of the University of Southampton. The Board is non-executive and provides advice on NC3Rs strategy, monitors delivery against the NC3Rs’ mission, and ensures that financial planning and risk management is robust.
Professor Paul Evans is Chair of Cardiovascular Science at the University of Sheffield, as well as Director of the Repair and Regeneration Research Node. His research uses a cross-disciplinary approach to study the biomechanical mechanisms that control atherosclerosis. His work has been recognised by the award of the Medawar Medal (British Transplantation Society), John French Lecture (British Atherosclerosis Society) and Michael Davies Award (British Cardiovascular Society).
Paul chairs the AWERB at the University of Sheffield and was previously Chair of the European Society for Cardiology Working Group on Atherosclerosis and Vascular Biology.
He is currently a member of the MRC’s Non-Clinical Fellowships Panel. He has served on the NC3Rs Project Grant and Fellowship panels and is the academic mentor to the NC3Rs Regional Programme Manager for Yorkshire and the North West.
A global reputation
Sheffield is a research university with a global reputation for excellence. We're a member of the Russell Group: one of the 24 leading UK universities for research and teaching.